» Articles » PMID: 25258510

Studies of Synthetic Chalcone Derivatives As Potential Inhibitors of Secretory Phospholipase A2, Cyclooxygenases, Lipoxygenase and Pro-inflammatory Cytokines

Overview
Specialty Pharmacology
Date 2014 Sep 27
PMID 25258510
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Arachidonic acid metabolism leads to the generation of key lipid mediators which play a fundamental role during inflammation. The inhibition of enzymes involved in arachidonic acid metabolism has been considered as a synergistic anti-inflammatory effect with enhanced spectrum of activity. A series of 1,3-diphenyl-2-propen-1-one derivatives were investigated for anti-inflammatory related activities involving inhibition of secretory phospholipase A2, cyclooxygenases, soybean lipoxygenase, and lipopolysaccharides-induced secretion of interleukin-6 and tumor necrosis factor-alpha in mouse RAW264.7 macrophages. The results from the above mentioned assays exhibited that the synthesized compounds were effective inhibitors of pro-inflammatory enzymes and cytokines. The results also revealed that the chalcone derivatives with 4-methlyamino ethanol substitution seem to be significant for inhibition of enzymes and cytokines. Molecular docking experiments were carried out to elucidate the molecular aspects of the observed inhibitory activities of the investigated compounds. Present findings increase the possibility that these chalcone derivatives might serve as a beneficial starting point for the design and development of improved anti-inflammatory agents.

Citing Articles

Synthesis of Anti-Inflammatory Drugs' Chalcone Derivatives and a Study of Their Conformational Properties Through a Combination of Nuclear Magnetic Resonance Spectroscopy and Molecular Modeling.

Georgiou N, Tzani A, Vavougyiou K, Papadopoulos C, Eleftheriadis N, Sket P Pharmaceuticals (Basel). 2025; 18(1).

PMID: 39861151 PMC: 11768734. DOI: 10.3390/ph18010088.


Design, synthesis and in silico molecular docking evaluation of novel 1,2,3-triazole derivatives as potent antimicrobial agents.

Reddy Baddam S, Avula M, Akula R, Battula V, Kalagara S, Buchikonda R Heliyon. 2024; 10(7):e27773.

PMID: 38590856 PMC: 10999864. DOI: 10.1016/j.heliyon.2024.e27773.


Diarylidene-N-Methyl-4-Piperidones and Spirobibenzopyrans as Antioxidant and Anti-Inflammatory Agents.

Rokkam S, Mas-Rosario J, Joshi B, Joshi M, Roy Choudhury A, Kar S Chem Biodivers. 2023; 20(9):e202300822.

PMID: 37537138 PMC: 10634312. DOI: 10.1002/cbdv.202300822.


Antimalarial and immunomodulatory potential of chalcone derivatives in experimental model of malaria.

Sinha S, Medhi B, Radotra B, Batovska D, Markova N, Bhalla A BMC Complement Med Ther. 2022; 22(1):330.

PMID: 36510199 PMC: 9743746. DOI: 10.1186/s12906-022-03777-w.


Blood-Brain Barrier Permeability Study of Potential Neuroprotective Compounds Recovered From Plants and Agri-Food by-Products.

Sanchez-Martinez J, Valdes A, Gallego R, Suarez-Montenegro Z, Alarcon M, Ibanez E Front Nutr. 2022; 9:924596.

PMID: 35782945 PMC: 9243654. DOI: 10.3389/fnut.2022.924596.


References
1.
Gomez-Rivera A, Aguilar-Mariscal H, Romero-Ceronio N, Roa-de la Fuente L, Lobato-Garcia C . Synthesis and anti-inflammatory activity of three nitro chalcones. Bioorg Med Chem Lett. 2013; 23(20):5519-22. DOI: 10.1016/j.bmcl.2013.08.061. View

2.
McInnes I, Schett G . Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol. 2007; 7(6):429-42. DOI: 10.1038/nri2094. View

3.
Bharate S, Mahajan T, Gole Y, Nambiar M, Matan T, Kulkarni-Almeida A . Synthesis and evaluation of pyrazolo[3,4-b]pyridines and its structural analogues as TNF-alpha and IL-6 inhibitors. Bioorg Med Chem. 2008; 16(15):7167-76. DOI: 10.1016/j.bmc.2008.06.042. View

4.
Kirkham B . Interleukin-1, immune activation pathways, and different mechanisms in osteoarthritis and rheumatoid arthritis. Ann Rheum Dis. 1991; 50(6):395-400. PMC: 1004446. DOI: 10.1136/ard.50.6.395. View

5.
Yang H, Gu J, Lin X, Grossman H, Ye Y, Dinney C . Profiling of genetic variations in inflammation pathway genes in relation to bladder cancer predisposition. Clin Cancer Res. 2008; 14(7):2236-44. DOI: 10.1158/1078-0432.CCR-07-1670. View